In this podcast series sponsored by Biopharmaceutical Section of American Statistical Association, key opinion leaders from pharmaceutical industry and regulatory agencies talk about upcoming statistical conferences and events, and discuss current issues in Biopharmaceutical statistics.
http://community.amstat.org/BioP/Home/
Gesamtlänge aller Episoden: 3 days 2 hours 4 minutes
Episode 107: SPAIG Committee
Scott Clark, Satrajit Roychoudhury, and Michelle Shardell discuss the Statistical Partnerships Among Academe, Industry & Government (SPAIG) Committee.
https://community.amstat.org/spaig/home
Episode 106: Rebbecca Wilson
Amy welcomes Rebbecca to the co-hosting chair while Christina enjoys some time off with her new baby (congrats)! The two discuss Rebbecca’s fascinating career thus far and how communication styles differ across male and female leaders.
Reference: https://hbr.org/2022/12/research-men-speak-more-abstractly-than-women
Episode 105: Adrian Coles and Wendy Martinez
Adrian and Wendy discuss imposter syndrome and being confident in your career.
Episode 104: Steve Ruberg
In our first episode of the new year, we interview Steve Ruberg, an ASA fellow with over 35 years of experience in the biopharmaceutical industry and an active proponent of the Tripartite Estimand Approach.
Episode 103: Tian Gu
Tian discusses her research in data integration methods and the bias arising from lack of representation.
Episode 102: LaShell Robinson
LaShell discusses diversity, equity, and inclusion in clinical trials.
Episode 101: Elizabeth Mannshardt-Hawk on Imposter Syndrome
Elizabeth discusses imposter syndrome and how to manage it in your statistical career. In collaboration with the ASA's Committee on Career Development (CCD website) .
Episode 100: Dionne Price, ASA President-Elect
Dionne talks about her journey in biostatistics and her goals for the ASA when she becomes President in 2023.
Episode 99: Amy LaLonde and Christina Nurse
This episode introduces new podcast cohosts Amy LaLonde and Christina Nurse! They take over hosting duties starting with Episode 101.
Episode 98: Safety Scientific Working Group
James Buchanan, Judy Li, Melvin Munsaka, and Bill Wang discuss the research of the Safety Scientific Working Group and their recent edited volume "Quantitative Drug Safety and Benefit Risk Evaluation: Practical and Cross-Disciplinary Approaches." https://tinyurl.com/2ucyer95